1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Gastroparesis Global Clinical Trials Review, H1, 2015

Gastroparesis Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 88 pages

Gastroparesis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, H1, 2015" provides data on the Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastroparesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Gastroparesis Global Clinical Trials Review, H1, 2015
Introduction 6
Gastroparesis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Gastroparesis to Gastrointestinal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Gastroparesis to Gastrointestinal Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Gastroparesis 22
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Gastroparesis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Gastroparesis 30
Oct 20, 2014: Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
Eli Lilly and Company 32
Clinical Trial Overview of Eli Lilly and Company 32
Theravance Biopharma U.S., Inc. 33
Clinical Trial Overview of Theravance Biopharma U.S., Inc. 33
Ocera Therapeutics, Inc. 34
Clinical Trial Overview of Ocera Therapeutics, Inc. 34
Johnson and Johnson 35
Clinical Trial Overview of Johnson and Johnson 35
Forest Laboratories, Inc. 36
Clinical Trial Overview of Forest Laboratories, Inc. 36
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
Evoke Pharma, Inc. 38
Clinical Trial Overview of Evoke Pharma, Inc. 38
Dong-A Socio Group 39
Clinical Trial Overview of Dong-A Socio Group 39
Allegiance Healthcare Corporation 40
Clinical Trial Overview of Allegiance Healthcare Corporation 40
Clinical Trial Overview of Top Institutes / Government 41
The National Institute of Diabetes and Digestive and Kidney Diseases 41
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 41
Mayo Clinic 42
Clinical Trial Overview of Mayo Clinic 42
Johns Hopkins University 43
Clinical Trial Overview of Johns Hopkins University 43
University of Florida 44
Clinical Trial Overview of University of Florida 44
Temple University 45
Clinical Trial Overview of Temple University 45
Royal Adelaide Hospital 46
Clinical Trial Overview of Royal Adelaide Hospital 46
Skane University Hospital 47
Clinical Trial Overview of Skane University Hospital 47
Columbia University 48
Clinical Trial Overview of Columbia University 48
Rouen University Hospital 49
Clinical Trial Overview of Rouen University Hospital 49
University of Iowa 50
Clinical Trial Overview of University of Iowa 50
Five Key Clinical Profiles 51
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 88

List of Tables

Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17
Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Gastroparesis Therapeutics, Global, Suspended Clinical Trials, 2015* 22
Gastroparesis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 23
Gastroparesis Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 31
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 32
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravance Biopharma U.S., Inc., 2015* 33
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 34
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 35
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015* 36
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Evoke Pharma, Inc., 2015* 38
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Socio Group, 2015* 39
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allegiance Healthcare Corporation, 2015* 40
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 41
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 42
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2015* 43
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 44
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Temple University, 2015* 45
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2015* 46
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Skane University Hospital, 2015* 47
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 48
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2015* 49
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Iowa, 2015* 50

List of Figures

Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17
Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.